美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Avalyn Pharma

33.57

-1.1000-3.17%

盤後：33.570.00000.00%19:30 EDT

成交量：13.29萬

成交額：454.62萬

市值：14.88億

市盈率：-14.41

高：35.39

開：35.15

低：33.56

收：34.67

52周最高：40.17

52周最低：24.15

股本：4,433.31萬

流通股本：1,666.67萬

量比：0.67

換手率：0.80%

股息：- -

股息率：- -

每股收益(TTM):-2.3300

每股收益(LYR):-87.7434

淨資產收益率：-68.34%

總資產收益率：-41.74%

市淨率：3.74

市盈率(LYR):-0.38

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Avalyn Pharma

交易所：

NASDAQ

成立時間：

2011

員工人數：

55

公司地址：

105 W First Street,Boston,Massachusetts,United States

官網：

http://www.avalynpharma.com

郵編：

02127

電話：

傳真：

- -

簡介：

Avalyn Pharma Inc.於2011年5月27日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司，開發吸入藥物以治療罕見的呼吸道疾病，包括進行性肺纖維化、特發性肺纖維化和其他間質性肺部疾病。

董事

名稱

職位

Lyn Baranowski

Chief Executive Officer,Director and President

David Friedman

Independent Director

Erin Lavelle

Independent Director

Heather Turner

Board Chair and Director

Jill Carroll

Independent Director

Jon Congleton

Independent Director

Kate Haviland

Independent Director

股東

名稱

職位

Lyn Baranowski

Chief Executive Officer,Director and President

Melissa Rhodes

Chief Operating Officer

Douglas Carlson

Chief Business Officer and Chief Financial Officer

Adam Golden

General Counsel

Howard M. Lazarus

Chief Medical Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/AVLN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AVLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","market":"US","secType":"STK","nameCN":"Avalyn Pharma","latestPrice":33.57,"timestamp":1789156800000,"preClose":34.67,"halted":0,"volume":132883,"hourTrading":{"tag":"盘后","latestPrice":33.57,"preClose":33.57,"latestTime":"19:30 EDT","volume":2690,"amount":90303.3,"timestamp":1789169407828,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03172771848860691,"floatShares":16666700,"shares":44333095,"eps":-2.33,"marketStatus":"休市中","change":-1.1,"latestTime":"09-11 16:00:00 EDT","open":35.15,"high":35.39,"low":33.56,"amount":4546169.27706,"amplitude":0.052783,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.33,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1777521600000,"exchange":"NASDAQ","adjPreClose":34.67,"postHourTrading":{"tag":"盘后","latestPrice":33.57,"preClose":33.57,"latestTime":"19:30 EDT","volume":2690,"amount":90303.3,"timestamp":1789169407828,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6682601684747959,"impliedVol":0.687,"impliedVolPercentile":0.8667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVLN\",,,,,undefined,":{"symbol":"AVLN","floatShares":16666700,"roa":"-41.74%","roe":"-68.34%","lyrEps":-87.743381,"volumeRatio":0.6682601684747959,"shares":44333095,"dividePrice":0,"high":35.39,"amplitude":0.052783,"preClose":34.67,"low":33.56,"week52Low":24.15,"pbRate":"3.74","week52High":40.17,"institutionHeld":0,"latestPrice":33.57,"eps":-2.33,"divideRate":0,"volume":132883,"delay":0,"ttmEps":-2.33,"open":35.15,"prevYearClose":18,"prevWeekClose":37.39,"prevMonthClose":34.73,"prevQuarterClose":32.92,"fiveDayClose":35.44,"twentyDayClose":36.58,"sixtyDayClose":28.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"AVLN","fiscalQuarterEnding":"2026/06","expectedEps":-1.03,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1781755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVLN","date":"2026-09-11","current":-14.407725,"percent":0.340659,"low":-16.842577,"twenty":-15.620135,"median":-14.133223,"eighty":-13.26914,"high":-8.833116,"avg":-14.352466,"sd":1.296311,"marketCap":1537028403},"quantilePoints":[{"date":"2026-05-01","current":-14.471589,"twenty":-13.343894,"median":-11.652352,"eighty":-9.960811,"marketCap":1233037266},{"date":"2026-05-08","current":-13.215324,"twenty":-14.430368,"median":-13.598092,"eighty":-13.264397,"marketCap":1125998425},{"date":"2026-05-15","current":-15.026112,"twenty":-14.666899,"median":-14.368536,"eighty":-13.42143,"marketCap":1280284879},{"date":"2026-05-22","current":-13.941602,"twenty":-14.643344,"median":-13.941602,"eighty":-13.42143,"marketCap":1187880255},{"date":"2026-05-29","current":-13.931787,"twenty":-14.643344,"median":-13.931787,"eighty":-13.215324,"marketCap":1187044014},{"date":"2026-06-05","current":-13.244767,"twenty":-14.510847,"median":-13.774754,"eighty":-13.102456,"marketCap":1128507148},{"date":"2026-06-12","current":-13.774754,"twenty":-14.471589,"median":-13.774754,"eighty":-13.161343,"marketCap":1173664159},{"date":"2026-06-18","current":-14.383258,"twenty":-14.479441,"median":-13.794383,"eighty":-13.204528,"marketCap":1225511097},{"date":"2026-06-26","current":-13.585419,"twenty":-14.649233,"median":-13.936694,"eighty":-13.238878,"marketCap":1284773093},{"date":"2026-07-02","current":-14.143275,"twenty":-14.655122,"median":-14.03484,"eighty":-13.265378,"marketCap":1337529476},{"date":"2026-07-10","current":-13.557292,"twenty":-14.643344,"median":-13.937009,"eighty":-13.265378,"marketCap":1282113107},{"date":"2026-07-17","current":-12.038425,"twenty":-14.576758,"median":-13.784568,"eighty":-13.15846,"marketCap":1138473879},{"date":"2026-07-24","current":-13.937009,"twenty":-14.519455,"median":-13.774754,"eighty":-13.193732,"marketCap":1318022914},{"date":"2026-07-31","current":-13.740119,"twenty":-14.495144,"median":-13.755125,"eighty":-13.157019,"marketCap":1299403014},{"date":"2026-08-07","current":-15.329303,"twenty":-14.523759,"median":-13.762486,"eighty":-13.165961,"marketCap":1449692206},{"date":"2026-08-14","current":-15.696852,"twenty":-14.725787,"median":-13.774754,"eighty":-13.189862,"marketCap":1621704615},{"date":"2026-08-21","current":-15.932863,"twenty":-15.087944,"median":-13.934398,"eighty":-13.227101,"marketCap":1646087817},{"date":"2026-08-28","current":-15.666815,"twenty":-15.573456,"median":-13.941602,"eighty":-13.249768,"marketCap":1618601298},{"date":"2026-09-04","current":-15.207667,"twenty":-15.433025,"median":-14.088821,"eighty":-13.261019,"marketCap":1571164886},{"date":"2026-09-11","current":-14.877252,"twenty":-15.620135,"median":-14.133223,"eighty":-13.26914,"marketCap":1537028403}],"updateTime":1789294464556},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":224094665,"yearFounded":2011,"employeeNum":55,"address":"105 W First Street,Boston,Massachusetts,United States","zipCode":"02127","officePhone":"(206) 707-0340","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.avalynpharma.com","stockEarnings":[{"period":"1week","weight":-0.1022},{"period":"1month","weight":-0.1019},{"period":"3month","weight":0.116},{"period":"6month","weight":0.865},{"period":"ytd","weight":0.865}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Avalyn Pharma Inc.於2011年5月27日在特拉華州註冊成立。該公司是一家臨床階段的生物製藥公司，開發吸入藥物以治療罕見的呼吸道疾病，包括進行性肺纖維化、特發性肺纖維化和其他間質性肺部疾病。","exchange":"NASDAQ","name":"Avalyn Pharma","nameEN":"Avalyn Pharma"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AVLN\",market:\"US\",,,undefined,":{"directors":[{"name":"Lyn Baranowski","position":"Chief Executive Officer,Director and President"},{"name":"David Friedman","position":"Independent Director"},{"name":"Erin Lavelle","position":"Independent Director"},{"name":"Heather Turner","position":"Board Chair and Director"},{"name":"Jill Carroll","position":"Independent Director"},{"name":"Jon Congleton","position":"Independent Director"},{"name":"Kate Haviland","position":"Independent Director"}],"executives":[{"name":"Lyn Baranowski","position":"Chief Executive Officer,Director and President"},{"name":"Melissa Rhodes","position":"Chief Operating Officer"},{"name":"Douglas Carlson","position":"Chief Business Officer and Chief Financial Officer"},{"name":"Adam Golden","position":"General Counsel"},{"name":"Howard M. Lazarus","position":"Chief Medical Officer"}]}}}